Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921606305> ?p ?o ?g. }
- W2921606305 endingPage "1206" @default.
- W2921606305 startingPage "1198" @default.
- W2921606305 abstract "Background: Tamoxifen (TAM) is a frequently used hormonal prodrug for patients with breast cancer that needs to be activated by cytochrome P450 2D6 (CYP2D6) into Zusammen-endoxifen (Z-END). Objective: The purpose of the study was to determine the association between CYP2D6*10 (c.100C>T) genotype and attainment of the plasma steady-state Z-END minimal threshold concentration (MTC) in Indonesian women with breast cancer. Methods: A cross-sectional study was performed in 125 ambulatory patients with breast cancer consuming TAM at 20 mg/day for at least 4 months. The frequency distribution of CYP2D6*10 (c.100C>T) genotypes (C/C: wild type; C/T: heterozygous mutant; T/T: homozygous mutant) was detected using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), the results of which were subsequently confirmed by sequencing. The genotypes were categorized into plasma Z- END concentrations of <5.9 ng/mL and ≥5.9 ng/mL, which were measured using ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Results: Percentages of C/C, CT, and T/T genotypes were 22.4%, 29.6%, and 48.8%, respectively. Median (25-75%) Z-END concentrations in C/C, C/T, and T/T genotypes were 9.58 (0.7-6.0), 9.86 (0.7-26.6), and 3.76 (0.9-26.6) ng/mL, respectively. Statistical analysis showed a significant difference in median Z-END concentration between patients with T/T genotype and those with C/C or C/T genotypes (p<0.001). There was a significant association between CYP2D6*10 (c.100C>T) genotypes and attainment of plasma steady-state Z-END MTC (p<0.001). Conclusion: There was a significant association between CYP2D6*10 (c.100C>T) and attainment of plasma steady-state Z-END MTC in Indonesian breast cancer patients receiving TAM at a dose of 20 mg/day." @default.
- W2921606305 created "2019-03-22" @default.
- W2921606305 creator A5008762753 @default.
- W2921606305 creator A5014878219 @default.
- W2921606305 creator A5017385048 @default.
- W2921606305 creator A5018923361 @default.
- W2921606305 creator A5036730013 @default.
- W2921606305 creator A5038807888 @default.
- W2921606305 creator A5065887730 @default.
- W2921606305 date "2019-11-11" @default.
- W2921606305 modified "2023-10-16" @default.
- W2921606305 title "Association of CYP2D6*10 (c. 100 C>T) Genotype with Z-END Concentration in Patients with Breast Cancer Receiving Tamoxifen Therapy in Indonesian Population" @default.
- W2921606305 cites W1508284217 @default.
- W2921606305 cites W1754092853 @default.
- W2921606305 cites W1808688610 @default.
- W2921606305 cites W1964945591 @default.
- W2921606305 cites W1978470279 @default.
- W2921606305 cites W1980756636 @default.
- W2921606305 cites W1986685858 @default.
- W2921606305 cites W2004192017 @default.
- W2921606305 cites W2047246104 @default.
- W2921606305 cites W2069469265 @default.
- W2921606305 cites W2071185486 @default.
- W2921606305 cites W2098867544 @default.
- W2921606305 cites W2104019649 @default.
- W2921606305 cites W2106377498 @default.
- W2921606305 cites W2113225995 @default.
- W2921606305 cites W2130377362 @default.
- W2921606305 cites W2135502243 @default.
- W2921606305 cites W2147099166 @default.
- W2921606305 cites W2147225212 @default.
- W2921606305 cites W2173858545 @default.
- W2921606305 cites W2261996569 @default.
- W2921606305 cites W2336794604 @default.
- W2921606305 cites W2407393655 @default.
- W2921606305 cites W2769256842 @default.
- W2921606305 cites W2792046032 @default.
- W2921606305 doi "https://doi.org/10.2174/1871530319666190306094617" @default.
- W2921606305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30843495" @default.
- W2921606305 hasPublicationYear "2019" @default.
- W2921606305 type Work @default.
- W2921606305 sameAs 2921606305 @default.
- W2921606305 citedByCount "5" @default.
- W2921606305 countsByYear W29216063052020 @default.
- W2921606305 countsByYear W29216063052021 @default.
- W2921606305 countsByYear W29216063052022 @default.
- W2921606305 crossrefType "journal-article" @default.
- W2921606305 hasAuthorship W2921606305A5008762753 @default.
- W2921606305 hasAuthorship W2921606305A5014878219 @default.
- W2921606305 hasAuthorship W2921606305A5017385048 @default.
- W2921606305 hasAuthorship W2921606305A5018923361 @default.
- W2921606305 hasAuthorship W2921606305A5036730013 @default.
- W2921606305 hasAuthorship W2921606305A5038807888 @default.
- W2921606305 hasAuthorship W2921606305A5065887730 @default.
- W2921606305 hasConcept C104317684 @default.
- W2921606305 hasConcept C121608353 @default.
- W2921606305 hasConcept C126322002 @default.
- W2921606305 hasConcept C134018914 @default.
- W2921606305 hasConcept C135763542 @default.
- W2921606305 hasConcept C153911025 @default.
- W2921606305 hasConcept C185592680 @default.
- W2921606305 hasConcept C2777176818 @default.
- W2921606305 hasConcept C2908647359 @default.
- W2921606305 hasConcept C29456083 @default.
- W2921606305 hasConcept C33664856 @default.
- W2921606305 hasConcept C530470458 @default.
- W2921606305 hasConcept C54355233 @default.
- W2921606305 hasConcept C71924100 @default.
- W2921606305 hasConcept C86803240 @default.
- W2921606305 hasConcept C90924648 @default.
- W2921606305 hasConcept C99454951 @default.
- W2921606305 hasConceptScore W2921606305C104317684 @default.
- W2921606305 hasConceptScore W2921606305C121608353 @default.
- W2921606305 hasConceptScore W2921606305C126322002 @default.
- W2921606305 hasConceptScore W2921606305C134018914 @default.
- W2921606305 hasConceptScore W2921606305C135763542 @default.
- W2921606305 hasConceptScore W2921606305C153911025 @default.
- W2921606305 hasConceptScore W2921606305C185592680 @default.
- W2921606305 hasConceptScore W2921606305C2777176818 @default.
- W2921606305 hasConceptScore W2921606305C2908647359 @default.
- W2921606305 hasConceptScore W2921606305C29456083 @default.
- W2921606305 hasConceptScore W2921606305C33664856 @default.
- W2921606305 hasConceptScore W2921606305C530470458 @default.
- W2921606305 hasConceptScore W2921606305C54355233 @default.
- W2921606305 hasConceptScore W2921606305C71924100 @default.
- W2921606305 hasConceptScore W2921606305C86803240 @default.
- W2921606305 hasConceptScore W2921606305C90924648 @default.
- W2921606305 hasConceptScore W2921606305C99454951 @default.
- W2921606305 hasIssue "8" @default.
- W2921606305 hasLocation W29216063051 @default.
- W2921606305 hasLocation W29216063052 @default.
- W2921606305 hasOpenAccess W2921606305 @default.
- W2921606305 hasPrimaryLocation W29216063051 @default.
- W2921606305 hasRelatedWork W2102591663 @default.
- W2921606305 hasRelatedWork W2135502243 @default.
- W2921606305 hasRelatedWork W2151950513 @default.
- W2921606305 hasRelatedWork W2370969125 @default.
- W2921606305 hasRelatedWork W2400372011 @default.